Gi-Young Sohn
Chief Executive Officer at ENZYCHEM LIFESCIENCES CORPORATION
Net worth: 6 M $ as of 2024-05-30
Gi-Young Sohn active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ENZYCHEM LIFESCIENCES CORPORATION | Director/Board Member | - | - |
| Chief Executive Officer | 2012-05-31 | - | |
| Chairman | 2012-05-31 | - | |
Bridget Lifesciences Corp.
 Bridget Lifesciences Corp. Financial ConglomeratesFinance Bridget Lifesciences Corp. functions as an investment holding South Korean company. Hye-Kyung Kim has been the CEO of the private company since 2003. | Chairman | 2002-12-31 | - |
Career history of Gi-Young Sohn
Training of Gi-Young Sohn
| Korea University | Graduate Degree |
Statistics
International
| South Korea | 4 |
Operational
| Chairman | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 2 |
| Consumer Services | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ENZYCHEM LIFESCIENCES CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Bridget Lifesciences Corp.
Bridget Lifesciences Corp. Financial ConglomeratesFinance Bridget Lifesciences Corp. functions as an investment holding South Korean company. Hye-Kyung Kim has been the CEO of the private company since 2003. | Finance |
- Stock Market
- Insiders
- Gi-Young Sohn
- Experience
